What are the diagnostic challenges associated with MAC lung disease, the latency period between symptom onset and diagnosis, the disease burden as we understand it; and finally, the geographical distribution of this infection in the United States?

What are the diagnostic challenges associated with MAC lung disease, the latency period between symptom onset and diagnosis, the disease burden as we understand it; and finally, the geographical distribution of this infection in the United States?

What are the diagnostic challenges associated with MAC lung disease, the latency period between symptom onset and diagnosis, the disease burden as we understand it; and finally, the geographical distribution of this infection in the United States?


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | NTM-Pulmonary Infection Intelligence Zone

Presenter

Julie Philley, MD

Julie Philley, MD

Chair of the Department of Medicine Chief of Pulmonary and Critical Care UT Health North Campus Tyler The University of Texas Health Sciences Center Houston, Texas